Depression drug shows promise for cognition.A recently released antidepressant antidepressant, any of a wide range of drugs used to treat psychic depression. They are given to elevate mood, counter suicidal thoughts, and increase the effectiveness of psychotherapy. has shown promising results in improving cognition in elderly patients with depression. Research presented at the annual meeting of the American Association American Association refers to one of the following professional baseball leagues:
Cymbalta Pharmacologic class: Selective serotonin and norepinephrine reuptake inhibitor Therapeutic class: Antidepressant Pregnancy risk category C ), 60 mg once daily, had twice as much improvement in verbal learning and recalling information than those given a sugar pill. By the end of the eight-week study, patients treated with Cymbalta demonstrated significantly greater improvement in cognition when compared with patients receiving sugar pills. In addition, 27.4% of Cymbalta-treated patients were virtually free of their depressive symptoms, a rate nearly double that seen with a sugar pill (14.7%). Significant improvements in depressive symptoms in Cymbalta-treated patients were seen as early as one week.[ILLUSTRATION OMITTED] Cymbalta is indicated for the treatment of major depression and the management of diabetic peripheral neuropathic neuropathic /neu·ro·path·ic/ (-path´ik) pertaining to or characterized by neuropathy. neuropathic pertaining to disease of the nervous system. pain. For more information, visit www.cymbalta.com. |
|
||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion